Hong Kong, China

Zhenguo Wu

This inventor holds 1 USPTO granted patent. Top assignee: Biotechnology Research Corporation Limited. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhenguo Wu. Retrieved from https://idiyas.com/inventor/zhenguo-wu-4gmrqfms

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhenguo Wu: Innovator in Neurodegenerative Disease Research

Introduction

Zhenguo Wu is a prominent inventor based in Hong Kong, China. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patent developments. His work focuses on identifying critical drug targets that can lead to advancements in diagnosis and treatment.

Latest Patents

Zhenguo Wu holds a patent titled "STAT3 and TYK2 as drug targets for neurodegenerative diseases." This invention highlights the importance of Stat3 and Tyk2 as targets for diagnosing neurodegenerative diseases, including Alzheimer's disease. Furthermore, these targets are crucial for drug development aimed at treating such conditions. He has 1 patent to his name.

Career Highlights

Wu is associated with Biotechnology Research Corporation Limited, where he continues to push the boundaries of research in neurodegenerative diseases. His work has garnered attention for its potential impact on the medical field.

Collaborations

Zhenguo Wu has collaborated with notable researchers, including Nancy Yuk-Yu Ip and Jerry Hsueh-Ching Wang. These partnerships have enhanced the scope and depth of his research endeavors.

Conclusion

Zhenguo Wu's innovative contributions to the understanding and treatment of neurodegenerative diseases position him as a key figure in the field. His work not only advances scientific knowledge but also holds promise for future therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…